A. Buntinx

1.3k total citations
23 papers, 1.0k citations indexed

About

A. Buntinx is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A. Buntinx has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A. Buntinx's work include Asthma and respiratory diseases (6 papers), Hormonal and reproductive studies (5 papers) and Sexual Differentiation and Disorders (4 papers). A. Buntinx is often cited by papers focused on Asthma and respiratory diseases (6 papers), Hormonal and reproductive studies (5 papers) and Sexual Differentiation and Disorders (4 papers). A. Buntinx collaborates with scholars based in Belgium, United States and Netherlands. A. Buntinx's co-authors include Wesley Tanaka, Inge De Lepeleire, P.J. De Schepper, Anne Van Hecken, Marleen Depré, Jonathan A. Tobert, Vito Angelo Giagulli, A. Vermeulen, P. De Schepper and Ian Holmes and has published in prestigious journals such as Journal of Clinical Investigation, Biochemical Pharmacology and European Urology.

In The Last Decade

A. Buntinx

23 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Buntinx Belgium 14 357 234 207 184 176 23 1.0k
M Fukushima Japan 18 324 0.9× 633 2.7× 164 0.8× 150 0.8× 142 0.8× 31 1.5k
Manlio Bolla Italy 23 409 1.1× 410 1.8× 384 1.9× 294 1.6× 124 0.7× 36 1.5k
Yosuke Kishimoto Japan 21 129 0.4× 323 1.4× 205 1.0× 239 1.3× 58 0.3× 41 1.1k
C.N. Hensby United Kingdom 24 618 1.7× 313 1.3× 163 0.8× 124 0.7× 77 0.4× 73 1.6k
Chang-Ping Hu China 27 176 0.5× 582 2.5× 187 0.9× 160 0.9× 333 1.9× 60 1.6k
N A Payne United States 17 318 0.9× 264 1.1× 197 1.0× 133 0.7× 82 0.5× 32 1.2k
Maurizio Degan Italy 20 184 0.5× 326 1.4× 248 1.2× 165 0.9× 129 0.7× 58 1.2k
Erkki Seppälä Finland 16 250 0.7× 107 0.5× 273 1.3× 101 0.5× 108 0.6× 60 872
Allan G. Howatson United Kingdom 14 450 1.3× 229 1.0× 101 0.5× 393 2.1× 186 1.1× 29 1.6k
A Zmuda Poland 16 619 1.7× 334 1.4× 244 1.2× 560 3.0× 115 0.7× 28 1.6k

Countries citing papers authored by A. Buntinx

Since Specialization
Citations

This map shows the geographic impact of A. Buntinx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Buntinx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Buntinx more than expected).

Fields of papers citing papers by A. Buntinx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Buntinx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Buntinx. The network helps show where A. Buntinx may publish in the future.

Co-authorship network of co-authors of A. Buntinx

This figure shows the co-authorship network connecting the top 25 collaborators of A. Buntinx. A scholar is included among the top collaborators of A. Buntinx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Buntinx. A. Buntinx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iannone, Raffaele, B.R. Bloem, John Palcza, et al.. (2011). The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol. Journal of Psychopharmacology. 26(2). 292–302. 16 indexed citations
2.
Hecken, Anne Van, Jules I. Schwartz, Marleen Depré, et al.. (2000). Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers. The Journal of Clinical Pharmacology. 40(10). 1109–1120. 285 indexed citations
3.
Ehrich, Elliot, D Hilliard, Arturo G. Porras, et al.. (1999). Demonstration of specific COX-2 inhibition by MK-966 in humans with supratherapeutic doses. Clinical Pharmacology & Therapeutics. 65(2). 164–164. 6 indexed citations
4.
Depré, Marleen, Beth S. Friedman, Wesley Tanaka, et al.. (1993). Biochemical activity, pharmacokinetics, and tolerability of MK-886, a leukotriene biosynthesis inhibitor, in humans. Clinical Pharmacology & Therapeutics. 53(5). 602–607. 18 indexed citations
5.
Friedman, Beth S., A. Buntinx, Wesley Tanaka, et al.. (1993). Oral Leukotriene Inhibitor (MK-886) Blocks Allergen-induced Airway Responses. American Review of Respiratory Disease. 147(4). 839–844. 126 indexed citations
6.
Gunning, Frans P., A Béchetoille, Erik A. Lippa, et al.. (1992). Sezolamide: Additivity to timolol twice daily. Eye. 6(5). 525–529. 4 indexed citations
7.
Margolskee, Dorothy J., John Y.‐K. Hsieh, Anne Van Hecken, et al.. (1992). Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man. European Journal of Clinical Pharmacology. 43(4). 427–430. 7 indexed citations
8.
Lammers, JW, Paul Van Daele, Marc Decramer, et al.. (1992). Bronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast—MK-0679) in asthmatic patients. Pulmonary Pharmacology. 5(2). 121–125. 18 indexed citations
9.
Depré, Marleen, et al.. (1992). Pharmacodynamics and tolerability of L-654,066, a steroid 5α-reductase inhibitor, in men. Clinical Pharmacology & Therapeutics. 52(4). 409–412. 5 indexed citations
10.
Depré, Marleen, Dorothy J. Margolskee, Anne Van Hecken, et al.. (1992). Dose-dependent kinetics of the enantiomers of MK-571, an LTD4-receptor antagonist. European Journal of Clinical Pharmacology. 43(4). 431–433. 6 indexed citations
11.
Kips, Johan, G.F. Joos, Inge De Lepeleire, et al.. (1991). MK-571, a Potent Antagonist of Leukotriene D 4 -induced Bronchoconstriction in the Human. American Review of Respiratory Disease. 144(3_pt_1). 617–621. 55 indexed citations
12.
Jong, E.M.G.J. de, et al.. (1991). Clinical and Biochemical Effects of an Oral Leukotriene Biosynthesis Inhibitor (MK886) in Psoriasis. Skin Pharmacology and Physiology. 4(4). 278–285. 18 indexed citations
13.
Schepper, P.J. De, Julianne Imperato‐McGinley, Anne Van Hecken, et al.. (1991). Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5α-reductase inhibitor. Steroids. 56(9). 469–471. 28 indexed citations
14.
Vermeulen, A., Vito Angelo Giagulli, P. De Schepper, & A. Buntinx. (1991). Hormonal Effects of a 5α-Reductase Inhibitor (Finasteride) onHormonal Levels in Normal Men and in Patients withBenign Prostatic Hyperplasia. European Urology. 20(1). 82–86. 22 indexed citations
15.
Lepeleire, Inge De, Anne Van Hecken, René Verbesselt, et al.. (1990). Lack of interaction between famotidine and warfarin.. PubMed. 10(3). 167–71. 6 indexed citations
16.
Vermeulen, A., Vito Angelo Giagulli, P. De Schepper, A. Buntinx, & E Stoner. (1989). Hormonal effects of an orally active 4‐azasteroid inhibitor of 5α‐reductase in humans. The Prostate. 14(1). 45–53. 87 indexed citations
17.
Tobert, Jonathan A., Vincent J. Cirillo, G Hitzenberger, et al.. (1981). Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio. Clinical Pharmacology & Therapeutics. 29(3). 344–350. 53 indexed citations
18.
Tobert, Jonathan A., Paul J. DeSchepper, T. B. Tjandramaga, et al.. (1981). Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states. Clinical Pharmacology & Therapeutics. 30(3). 385–389. 24 indexed citations
19.
Verbeeck, Roger K., et al.. (1980). Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic. Biochemical Pharmacology. 29(4). 571–576. 19 indexed citations
20.
Cremer, C., et al.. (1978). A Single Dose Study Comparing the Analgesic Effects of Diflunisal, Acetylsalicylic Acid, and Placebo in Pain following Meniscectomy. Journal of International Medical Research. 6(3). 172–179. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Fukushima Breakdown of academic impact, for papers by Manlio Bolla Breakdown of academic impact, for papers by Yosuke Kishimoto Breakdown of academic impact, for papers by C.N. Hensby Breakdown of academic impact, for papers by Chang-Ping Hu Breakdown of academic impact, for papers by N A Payne Breakdown of academic impact, for papers by Maurizio Degan Breakdown of academic impact, for papers by Erkki Seppälä Breakdown of academic impact, for papers by Allan G. Howatson Breakdown of academic impact, for papers by A Zmuda
Rankless by CCL
2026